Olaratumab

olaratumab · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Olaratumab, covering 2017-01-16 to 2024-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Olaratumab (LY3012207) Patient Access for Soft Tissue Sarcoma